Nuclear Medicine
131I MIBG BACON (R&D)
Name:
131I MIBG Bacon (R&D)
Active Principle:
131I- Meta Iodo Benzylguanidine or 131I- Iobenguane
Therapeutic Action:
It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas, among other pathologies.
Nuclear Medicine
131I MIBG BACON (R&D)
Name:
131I MIBG Bacon (R&D)
Active Principle:
131I- Meta Iodo Benzylguanidine or 131I- Iobenguane
Therapeutic Action:
It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas, among other pathologies.
RELATED PRODUCTS
-
IODOSOL 123I (R&D)
IODOSOL 123I (R&D)Sodium iodide (123I) solution is indicated as a diagnostic agent to evaluate thyroid function and/or morphology by scintigraphy and radioactive iodine uptake test. -
177Lu DOTATATE (I+D)
177Lu DOTATATE (I+D)It is a radiolabeled somatostatin analog indicated for: - The treatment of gastroenteropancreatic tumors positive for the somatostatin receptor. Neuroendocrine tumors (GEP-NETs), including the foregut...

